About Labviva
Labviva is a company based in Cambridge (United States) founded in 2017 by Nicholas Rioux, Aaron Miramontes, and Siamak Baharloo. Labviva has raised $55.75 million across 5 funding rounds from investors including 53 Stations, Biospring and B Capital. The company has 8 employees as of December 31, 2020. Labviva offers products and services including Purchasing Platform, Inventory Management System, and Dashboard & Analytics. Labviva operates in a competitive market with competitors including Cytiva, PerkinElmer, Zageno, Fortis Life Sciences and Leica Biosystems, among others.
- Headquarter Cambridge, United States
- Employees 8 as on 31 Dec, 2020
- Founders Nicholas Rioux, Aaron Miramontes, Siamak Baharloo
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Labviva, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$55.75 M (USD)
in 5 rounds
-
Latest Funding Round
$25 M (USD), Series B
Jan 13, 2025
-
Investors
53 Stations
& 4 more
-
Employee Count
8
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Labviva
Labviva offers a comprehensive portfolio of products and services, including Purchasing Platform, Inventory Management System, and Dashboard & Analytics.
Platform for optimizing life sciences spend and supplier integration.
Automates stock tracking and reduces costs in life sciences operations.
Provides real-time data insights for purchasing and inventory decisions.
People of Labviva
Unlock access to complete
Funding Insights of Labviva
Labviva has successfully raised a total of $55.75M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Labviva
Labviva has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include 53 Stations, Biospring and B Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by 53 Stations.
|
Locked | Locked | Locked | |
|
Biospring is engaged in partnering with pharma services businesses.
|
Locked | Locked | Locked | |
|
Multistage investments are directed toward technology, healthcare, and climate sectors.
|
Locked | Locked | Locked |
Investor details for Labviva
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Labviva
Investment portfolio details for Labviva
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Labviva
Detailed financials for Labviva
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Labviva Comparisons
Peer comparison for Labviva
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Labviva
Labviva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytiva, PerkinElmer, Zageno, Fortis Life Sciences and Leica Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Life science software and research products are provided online.
|
|
| Locked | Locked | Locked |
Medical instruments and supplies are manufactured and provided for healthcare.
|
|
| Locked | Locked | Locked |
Marketplace and life science research community for biotech research kits
|
|
| Locked | Locked | Locked |
A trusted partner in life sciences and diagnostics solutions.
|
|
| Locked | Locked | Locked |
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide.
|
Detailed competitors of Labviva
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Labviva
Complete news archive for Labviva
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Labviva
Labviva was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Labviva is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Siamak Baharloo is the current CEO of Labviva. They have also founded this company.
Labviva is a funded company, having raised a total of $55.75M across 5 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Labviva is 8.
Labviva was founded in 2017 in Cambridge, United States. An AI-powered digital marketplace is maintained to connect researchers with suppliers of reagents, chemicals, and instrumentation within the life sciences sector. Procurement systems are integrated to facilitate transactions. Operations focus on streamlining access to essential lab materials across the industry.
Labviva's top competitors include Cytiva, Zageno and PerkinElmer.
Labviva offers Purchasing Platform, Inventory Management System, and Dashboard & Analytics.
Labviva has 5 investors. Key investors include 53 Stations, Biospring, B Capital, Glasswing Ventures, and Senator Investment Group.